Gemcitabine for Non Small Cell Lung Cancer User Reviews

Brand names: Gemzar, Infugem

Rating: 9.0

Gemcitabine has an average rating of 9.0 out of 10 from a total of 3 reviews for the treatment of non small cell lung cancer. 100% of reviewers reported a positive experience, while 0% reported a negative experience.

10		33%
9		33%
8		33%
7		0%
6		0%
5		0%
4		0%
3		0%
2		0%
1		0%

Anonymous
Taken for 1 to 6 months
February 18, 2024

Gemcitabine "This is so much better than what I had before. The worst side effect is pain around the base of my head and down the side of my neck like a crick the second through the third day after treatment. So bad, I usually have to take a pain pill. I have not seen this on any reviews, so I was wondering if anyone else had this experience."

8 / 10

Was this helpful?Yes No

6 Report

Chi...
Taken for 1 to 6 months
January 6, 2018

"I had written back in September 2017 about my experience with different chemo and immunotherapy drugs for my non-small cell lung cancer. After not having had positive results, the doctor recommended nine cycles of gemcitabine. I completed the nine chemos in October; in November, I had a lung scan, which showed the cancer was detained and that there was a discrete decrease. I am relieved and happy. My cancer is Stage IV."

9 / 10

Was this helpful?Yes No

17 Report

joh...
Taken for 1 to 6 months
February 10, 2025

Gemcitabine "I have had the base of the skull pain, not too bad. Advil worked, 2-3 days gone."

10 / 10

Was this helpful?Yes No

0 Report

Are you taking this medicine?

Your review helps others make informed decisions.

Write a review

Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.